P46376 Cell and Gene Therapy
Download Brochure Request

Register your interest

Comments

Register your interest

Comments

Cell and Gene Therapy

15 – 16 May 2019, Shanghai Marriott Hotel Parkview, China

Register Your Interest Download Brochure

LOCAL CHINA COMPANIES RATES AVAILABLE. 中国企业可享有独家优惠价!
SPECIAL GROUP RATES FOR 2 OR MORE. 2名及以上代表注册立享团队优惠价。SEE PRICING BELOW.

overview

The cell therapy market is exploding with opportunities, and the total market volume for CAR-T therapy alone is expected to reach USD 1 trillion by 2030. China boasts more cell therapy trials than the US, and it is increasingly leveraging its strategic advantage in context to labour costs, precision manufacturing, and now also a more accommodating regulatory regime for this sector.

Part of the 5th Biopharma Development Week, IBCs Cell and Gene Therapy summit will be one of 5 colocated events straddling the entire biopharma value chain. Focusing on investment, regulation, trials and development, the cell therapy market segment will be adrressed as a whole, alongside pricing and commercialisation developments.

Discussion themes

  • Regulatory developments in the region, and China
  • Working with CFDA guidelines on Research and Evaluation of Cell Therapy Products
  • Best practice as defined by regulation for selection of animal models for non-clinical studies and clinical data collection
  • The in’s and out of CAR-T trials
  • Cell therapy manufacturing – regulatory requirements, technology and innovation
  • Improving, manufacturing, development and quality control capabilities
  • Testing benchmarks for product quality release and drug clearing procedures
  • Approval process and guidelines for cell therapy products
  • CAR-T therapy market outlook, and CD19 developments
  • Commissioning CAR-T cell preparation facilities in China
  • Developments in viral and nonviral vectors for gene delivery
  • Innovative applications of CRISPR technology
  • Government opinions on medical insurance and pricing for cell therapy products
  • Defining the growth path of cell therapy in future

Part of

5th Annual BioPharma Development and Production Week »

With demonstrated success year on year, IBCs BDP Week in China enjoys unparalleled industry support. Known for generating knowledge, creating business opportunities, and bringing innovative ideas to the table, the BDP Week is now more impactful than ever with 5 high level conferences, learning seminars, focused trade show and business matching to boot.

Co located conferences

The BDP Party!

When: Wednesday, 15 May 2019 at 6.30pm
Where: Shanghai City Bistro, Level 1, Shanghai Marriott Parkview Hotel
Cost: CNY 350 / USD 50 net (inclusive of buffet dinner and free flow wine / beer)

  • Registration is not limited to conference participants and we encourage all who are in the BDP industry to attend.
  • Dinner will only proceed when we have reached 100 participants.
  • Payment is only required when the dinner is confirmed.
  • Participants list for the dinner will be made available online once the registration reaches 100 participants.

CNY Pricing

  • 2 Day Conference: CNY 6,500
  • Group of 2 or more delegates: CNY 5,000
  • Group of 4 or more delegates: CNY 4,500
  • Pre Conference Workshop: CNY 1,000
  • Gala Dinner: CNY 350

Sponsorship

Partnership and Profile Building Opportunities are Now Available!
Contact us today to find out how you can position your company as a market leader at this event, and to explore the range of branding and marketing opportunities available.

speakers

Judith Li

Partner, Lilly Asia Ventures, Hong Kong

Feng Tao

Founding Partner, Biotrack Capital, China

He Ting

Chief Executive Officer, ImmunoChina, China

Dong Wei

CEO, Edigene, China

Peter Luo

CEO, Adagene Pharma, China

Jonathan Zhao 4th Annual Bioprocess and Technology 2018

Jonathan Zhao

Co-Founder and Executive Chairman, TRANSCENTA HOLDING, China

Dr. Jimmy Zhang

Venture Partner, Lilly Asia Ventures, China

Chelsea Zhang

Partner, Ping An Ventures, China

Amy Tang

Venture Partner, Healthcare, Qiming Venture Partners, China

Dr. Kevin Li

Managing Partner, LYZZ Capital Advisors, China

Dody Bautista

Chief Scientist, Sibiono GeneTech, China

Jieyu Zou

Vice President, Lilly Asia Ventures, China

Dr. Alvin Luk

Senior Vice President and Chief Medical Officer, Shanghai Henlius Biotech, Inc., China

Shuyuan Yao

General Manager, Wuxi ATU Co., Ltd., China

Jiansong Tong

Director and Head of CAR-T Cell Therapy, Shanghai Hengrui Pharmaceutical, China

Jun Wang

Marketing Manager, PALL® Biotech, China

Richard Wang

CEO, Fosun Kite Biotech, China

Paolo Morgese

Director for EU Market Access and Member Relations, Alliance for Regenerative Medicine, Switzerland

Sumimasa Nagai

Deputy Director of the Translational Research Centre / Clinical Expert Advisor at the Office of New Drug V (Oncology) and Companion Diagnostics Working Group, University of Tokyo Hospital / Pharmaceuticals and Medical Devices Agency, Japan

Daniel Takefman

Head of Regulatory Affairs, Spark Therapeutics, United States

Chen-Yuan Lin

Ward Director and Attending Physician at the Division of Hematology and Oncology, China Medical University Hospital, Taiwan

Sandy Qlintang

Deputy Director of Stem Cell and Cancer Institute, PT Kalbe Farma, Indonesia

Dr. Steve Oh

Institute Scientist and Director, Stem Cell Bioprocessing, Bioprocessing Technology Institute, A*STAR, Singapore

Morakot Papassiripan

Pharmacist at the Professional Level at the Biological Sub-Division, Bureau of Drug Control, Food and Drug Administration of Thailand, Thailand

David Bekkers

Officer for Innovation, Technology & Science, Holland Innovation Network in China, Netherlands

Dr Jerry Dong

Vice President of CMC and Regulatory Affairs, Shanghai Henlius Biotech, Inc.

Dr Lin Shiwen

Vice President of Downstream Process Development, WuXi Biologics, China

Dr. Jerry Yang

Senior Vice President, Process & Product Development, Hangzhou JUST Biotherapeutics, China

when & where

15 - 16 May 2019

Shanghai Marriott Hotel Parkview
333 Guang Zhong Road West, Jing’an District
Shanghai, 200072 China
Phone:+86 21 3669 8888
Fax:+86 21 3669 8668

Cartrina Wang 王洁琼 | Senior Sales Manager-EBC
mhrs.shamp.catering.asstmgr1@marriott.com
T: 86 21 3669 8666 | M:13585605981

https://www.marriott.com/hotels/travel/shamp-shanghai-marriott-hotel-parkview/

contact

Still have a question?

Speaking Opportunities
Thian Si Ying
+65-6508 2446
 
SiYing.Thian@ibcasia.com.sg

Sponsorship Opportunities
Yvonne Leong
+65 6508 2489

Yvonne.Leong@ibcasia.com.sg

Media & Association Partnership Opportunities
Eileen Tan
+65 6508 2462
eileen.tan@ibcasia.com.sg

sponsors

exhibitors

Partners

Conference Partner Conference Partner

STAY UPDATED ON OUR NEWS & EVENTS

IBC Asia is Singapore's leading event organiser. We conceive, develop and promote our own B2B industry conferences and corporate training courses, and offer tailored managed event solutions.

Find out more